Trial Profile
Potential pharmacokinetic interaction between pradigastat and rosuvastatin in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Pradigastat (Primary) ; Rosuvastatin
- Indications Hyperlipoproteinaemia type I
- Focus Pharmacokinetics
- Sponsors Novartis
- 29 Oct 2015 New trial record